Published 1 year ago • loading... • Updated 1 year ago

Drug offers ‘wonderful’ breakthrough in treatment of asbestos-linked cancer

An experimental drug, ADI-PEG20, combined with chemotherapy, increased mesothelioma patients' three-year survival rate fourfold.
Mesothelioma cancer cells lack ASS1 protein, hindering their growth when ADI-PEG20 blocks arginine absorption.
Mick, an ADI-PEG20 trial participant, celebrated his 80th birthday after his mesothelioma remained under control post-treatment.

Insights by Ground AI

Does this summary seem wrong?

10 Articles

All

Left

Center

Right

Scripps News

Drug said to be a breakthrough in asbestos-linked mesothelioma cancers

A trial including participants in multiple countries found a new drug cuts off the nutrient supply for tumors, dramatically improving survival rates.

1 year ago·Atlanta, United States

Read Full Article

Gloucestershire Live

Breakthrough in cancer treatment as new inhalable drug found effective

Findings from a recent study show that a new way to deliver anti-cancer treatment is proving effective

1 year ago·Gloucester, United Kingdom

Read Full Article

The Guardian

Drug offers ‘wonderful’ breakthrough in treatment of asbestos-linked cancer

Medicine used alongside chemotherapy in trials quadrupled three-year survival rates for mesotheliomaScientists have developed a drug to treat mesothelioma, a notoriously hard-to-treat cancer linked to asbestos, in the biggest breakthrough in two decades.Thousands of people are diagnosed with the disease globally every year, which tends to develop in the lungs and is mainly caused by exposure to asbestos at work. It is aggressive and deadly, and …

1 year ago·London, United Kingdom

Read Full Article

The Independent

+2 Reposted by 2 other sources

Cancer breakthrough as doctors celebrate new ‘wonder drug’

The new drug cuts of the tumour’s foos supply and could be used to treat mesothelioma

1 year ago·London, United Kingdom

Read Full Article

UPI

Experimental drug shows promise in treating cancer linked to asbestos

An experimental drug called ADI-PEG20 increased average survival of mesothelioma patients by 1.6 months, and quadrupled the three-year survival rate, when combined with traditional chemotherapy, trial results show.

1 year ago·Washington, United States

Read Full Article

Medical Xpress

New treatment for a rare and aggressive cancer improves survival rates in breakthrough clinical trial

An innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but rapidly fatal type of cancer with few effective treatment options, according to results from a clinical trial led by Queen Mary University of London. The findings have been published in JAMA Oncology.

1 year ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year